Internship

PAT Intern

Confirmed live in the last 24 hours

Zoetis

Zoetis

5,001-10,000 employees

Compensation Overview

$16 - $40.30Hourly

+ $16.00 for Associate-level + $20.00 for Undergraduate-level + $32.50 for Graduate-level + $36.00 for Doctorate-level + $17.00 for Associate-level in certain states + $22.00 for Undergraduate-level in certain states + $36.40 for Graduate-level in certain states + $40.30 for Doctorate-level in certain states

Kalamazoo, MI, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Python
Machine Learning
Data Analysis
Requirements
  • Currently pursuing a master’s or PhD degree in Chemistry, Analytical Chemistry, Biochemistry, Engineering, Pharmaceutical Sciences, or a related field.
  • Strong analytical and problem-solving skills, with a foundation in experimental design and data analysis.
  • Familiarity with laboratory techniques; experience with spectroscopic or analytical instruments (e.g., NIR, refractometry) is a plus.
  • Familiarity with chemometrics and machine learning techniques, with proficiency in Python or similar programming languages.
  • Ability to work collaboratively in a team environment, with strong communication and documentation skills.
  • Detail-oriented, with a commitment to quality and regulatory standards in pharmaceutical manufacturing.
  • Available for full-time employment for 9–12 weeks during May–August 2025.
  • Legally authorized to work in the United States.
Responsibilities
  • Support the development, testing, and validation of PAT methods to ensure product quality and consistency.
  • Conduct experiments using PAT tools to analyze formulation components and monitor product consistency.
  • Collaborate with cross-functional teams, including formulation and analytical scientists, to refine and document analytical methods.
  • Collect, analyze, and interpret data from PAT instruments, and develop models to optimize analytical performance.
  • Document procedures and findings, creating technical reports and standard operating procedures (SOPs) to support method validation and regulatory compliance.
  • Engage actively in informal networking and mentoring sessions, as well as formal symposiums.
  • Present scientific findings and project outcomes at the conclusion of the internship.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Parsippany-Troy Hills, New Jersey

Founded

1952

Simplify Jobs

Simplify's Take

What believers are saying

  • Zoetis benefits from the growing animal health market, projected to reach $112.33 billion by 2030.
  • The rise of pet insurance boosts demand for Zoetis' advanced veterinary services and products.
  • Zoetis' focus on AI integration in diagnostics aligns with accelerating industry trends.

What critics are saying

  • Emerging biotech firms in animal health could threaten Zoetis' market share.
  • Departure of key legal personnel may cause transitional challenges in compliance areas.
  • Competitors' rapid digital solutions advancement may outpace Zoetis' technological offerings.

What makes Zoetis unique

  • Zoetis is the world's leading animal health company, showcasing strong market leadership.
  • The company launched Vetscan OptiCell, a screenless hematology analyzer, in January 2025.
  • Zoetis collaborates with Colorado State University to advance sustainable animal production research.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Hybrid Work Options

Company News

MarketBeat
Feb 27th, 2025
World Equity Group Inc. Invests $342,000 in Zoetis Inc. (NYSE:ZTS)

World Equity Group Inc. invests $342,000 in Zoetis Inc. (NYSE:ZTS).

MarketBeat
Feb 22nd, 2025
Tandem Investment Advisors Inc. Invests $32.19 Million in Zoetis Inc. (NYSE:ZTS)

Tandem Investment Advisors Inc. invests $32.19 million in Zoetis Inc. (NYSE:ZTS).

MarketBeat
Jan 17th, 2025
Miracle Mile Advisors LLC Makes New $272,000 Investment in Zoetis Inc. (NYSE:ZTS)

Miracle Mile Advisors LLC makes new $272,000 investment in Zoetis Inc. (NYSE:ZTS).

TipRanks
Jan 13th, 2025
Zoetis Highlights Growth at J.P. Morgan Conference

Zoetis announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference, showcasing its exemplary 2024 performance and strategic growth initiatives.

Stock Titan
Jan 7th, 2025
Is Zoetis Inc. (NYSE: ZTS) Overvalued? Or Is It Worth Buying Now?

BetterInvesting Magazine has selected Zoetis (NYSE: ZTS) as its 'Stock to Study' for the March 2025 issue, suggesting the stock warrants further investigation by investors.